Workflow
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire· 2025-05-16 12:00
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a fireside chat at the 3rd Annual H.C. Wainwright BioConnect Investor Conference, on Tuesday, May 20, 2025 at 11:30 a.m. ET at the Nasdaq headquarters in New York City, New York. Investors interested in scheduling a meeting with the Company's management team sho ...
IZEA Announces Commencement of a Modified Dutch Auction Tender Offer to Repurchase up to $8.7M of its Common Stock
GlobeNewswire· 2025-05-16 12:00
ORLANDO, Fla., May 16, 2025 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), a leading influencer marketing company that makes Creator Economy solutions for marketers, announced today that it has commenced a modified “Dutch auction” tender offer (the “Offer”) to repurchase up to $8,700,000 of its common stock. Under the terms of the Offer, IZEA is offering to purchase shares of its common stock at a price not less than $2.30 and not more than $2.80 per share, which maximum price equals approximately ...
PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025
GlobeNewswire· 2025-05-16 12:00
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical company focused on ketamine for unmet medical needs, today announced the U.S. Food and Drug Administration (FDA) has extended the approval goal date for the review of its new drug application for ketamine. The new approval goal date is August 9, 2025, revised from the previous date of June 4, 2025. The extension allows the FDA additional time to review add ...
Concorde International Group Reports Full-Year 2024 Financial Results and Provides Business Update
GlobeNewswire· 2025-05-16 12:00
Gross profit increased 20.8% in 2024 compared to 2023SINGAPORE, May 16, 2025 (GLOBE NEWSWIRE) -- Concorde International Group Ltd. (NASDAQ: CIGL) (“Concorde” or the “Company”), an integrated security services provider that combines physical manpower and innovative technology to deliver effective security solutions, today announced financial results and provided a business update for the year ended December 31, 2024. 2024 Financial Highlights Maintained stable revenues at approximately $10.5 million for the ...
Global Technologies, Ltd. Files Third Quarter 10-Q with SEC Highlighting Substantial Revenue Growth and Strategic Expansion
GlobeNewswire· 2025-05-16 12:00
GREENSBORO, NC, May 16, 2025 (GLOBE NEWSWIRE) -- Global Technologies, Ltd. (OTC PINK: GTLL) (“Global” or the “Company”), a publicly traded, multi-operational company driving innovation and sustainable growth across the technology and service sectors, today announced the filing of its Quarterly Report on Form 10-Q for the period ending March 31, 2025. The report reflects significant revenue growth, with the Company reporting a 473% increase in revenue compared to the same period last year. Additional financi ...
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth
GlobeNewswire· 2025-05-16 12:00
Company in Advanced Discussions to Restructure Convertible Debt and Unlock Shareholder ValuePotential Agreement Expected to Improve Financial Flexibility and Reduce Dilution Pressure WEST PALM BEACH, FL, May 16, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in primary care, today announced that it is in advanced discussions with Catheter Precision, ...
Algorhythm Holdings Reports First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-16 12:00
Fort Lauderdale, FL, May 16, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – an AI technology and consumer electronics holding company, announced today its results of operations for the three-month period ended March 31, 2025. Q1 2025 Financial Highlights Algorhythm reported revenue of $2.0 million for the three months ended March 31, 2025 compared to $2.4 million for the three months ended March 31, 2024. Gross profit margin increased by 4.4% to 25.1% from 20.7% compared ...
Richtech Robotics Expands ADAM Robot Capabilities with AI Powered Artisanal Espresso System
GlobeNewswire· 2025-05-16 12:00
New system utilizes advancements in physical AI to provide customers efficient and precise artisanal coffee products Las Vegas, NV, May 16, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a Nevada-based provider of AI-driven service robots, is expanding the capabilities of its AI-powered barista robot, ADAM, with a new artisanal espresso system debuting at the National Restaurant Association Show at McCormick Place Convention Center in Chicago from May 17 ...
JOYY to Announce First Quarter 2025 Financial Results on May 26, 2025
GlobeNewswire· 2025-05-16 12:00
SINGAPORE, May 16, 2025 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced that it plans to release its first quarter 2025 financial results after the U.S. market closes on May 26, 2025. The Company’s management will host an earnings conference call at 9:00 PM U.S. Eastern Time on Monday, May 26, 2025 (9:00 AM Singapore/Hong Kong Time on Tuesday, May 27, 2025). Details for the conference call are as follows: Event Title:JOYY Inc. First Quarte ...
Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference
GlobeNewswire· 2025-05-16 11:30
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”) a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that management will attend the Sidoti Micro-Cap Conference and the A.G.P. Virtual Healthcare Conference in May 2025. Quantum BioPharma Head of Finance and M&A Jason Sawyer will attend the Sidoti Micro-Cap Conference on May 21 and the A.G.P. Virtua ...